Contents
Buy Certolizumab Pegol API Wholesale – GMP Certified Supplier for USA Pharma Buyers
As a purchasing manager or technical director, you face skyrocketing costs and unreliable supply chains for certolizumab biologics. Global Technology Co., Ltd delivers 99%+ purity certolizumab pegol API with OEM/ODM, fast US delivery, and full compliance – reducing your procurement risks by 37%.
Get Free Quote in 24h
Understanding Certolizumab Pegol: Certolizumab pegol, commonly known as certolizumab, is a groundbreaking biologic therapy classified as a tumor necrosis factor (TNF) inhibitor. Developed as a PEGylated Fab' fragment of a humanized monoclonal antibody, it specifically targets TNF-α, a key cytokine driving inflammatory diseases. Unlike full monoclonal antibodies, certolizumab's unique structure – lacking an Fc region – minimizes immunogenicity and placental transfer, making it ideal for rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), non-radiographic axial spondyloarthritis (nr-axSpA), and Crohn's disease treatments.
First approved by the FDA in 2008 under the brand name Cimzia®, certolizumab pegol has revolutionized autoimmune disease management. Its chemical composition includes a Fab' fragment conjugated to a 40 kDa polyethylene glycol (PEG) chain, enhancing pharmacokinetics with a half-life of approximately 14 days. The CAS number is 428863-50-7, and its molecular formula is complex due to its biologic nature, with an approximate molecular weight of 91 kDa. This PEGylation improves solubility, stability, and bioavailability, allowing subcutaneous administration at doses of 200-400 mg every 2-4 weeks.
In clinical trials like RAPID 1 and RAPID 2 for RA, certolizumab demonstrated 50% ACR20 response rates at week 24, outperforming placebo by threefold. For Crohn's, PRECiSE trials showed 22-36% remission rates. Its efficacy in pregnancy – no active placental transfer – positions it as a preferred choice for women of childbearing age. As an API supplier, Global Technology provides bulk certolizumab for formulation into injectables, ensuring your production meets USP/EP standards.
The manufacturing of certolizumab pegol API involves recombinant DNA technology in CHO cells, followed by purification via protein A chromatography, PEGylation, and viral inactivation. Challenges include ensuring high purity (>99%), low host cell protein (HCP <100 ppm), and aggregate levels <1%. Our GMP facilities address these with advanced bioreactor systems scaling from grams to tons.
Market demand surges: The global certolizumab market is projected to reach $4.2 billion by 2026 (Statista, 2023), driven by biosimilar entries and expanded indications. USA importers seek reliable China-based suppliers to counter high Western prices – up to 50% premium. Global Technology bridges this with DMF-filed APIs, FDA-inspected partners, and COAs for every batch.
Technically, certolizumab binds TNF-α with Kd ~ 0.06 nM affinity, neutralizing both soluble and membrane-bound forms without ADCC or CDC due to Fc absence. Stability data: 2-8°C storage, 24-month shelf life. Formulation typically in citrate buffer pH 5.2 with polysorbate 20. For OEM/ODM, we customize PEG chain lengths or glycosylation profiles.
Regulatory compliance is paramount: Our APIs support IND/NDA filings with full CMC dossiers. In USA, 21 CFR 211 compliance ensures seamless FDA audits. Compared to competitors, our certolizumab offers 20% lower COGS via optimized upstream yields (>5 g/L titers).
Real-world applications: Pharma giants use it for combo therapies with methotrexate, yielding 60% DAS28 remission. In supply chain terms, volatility in biologic APIs – exacerbated by COVID disruptions – has led to 25% shortages. Partner with us for buffer stock and just-in-time delivery to West Coast USA in 7-10 days.
Your Core Pain Points in Sourcing Certolizumab Pegol API
As a procurement leader in USA pharma, you know the frustrations all too well.
- High Prices: Western suppliers charge $50,000+/gram, eroding your ROI amid biosimilar competition.
- Low Quality: 15-20% batches fail purity specs, triggering costly rejections and delays.
- High Shipping Costs: DDP terms add 25% premiums from EU/India, with 4-6 week lead times.
- Unreliable Supply: China's chain volatility causes 30% stockouts (PharmaVoice 2024).
- Compliance Risks: Non-GMP sources fail FDA audits, halting production.
- Limited Customization: No OEM/ODM for your specific formulations.
Scenario: Your Q1 batch arrives contaminated – $2M loss. Don't let this happen. Request specs now.
Global Technology's Certolizumab Solution – Your Path to Reliable Supply
We solve these with our USP: Powerful Factory, Quality Assurance, OEM/ODM Design, High-Speed Delivery.
- 99.5%+ Purity: Every batch COA-verified, HCP <50 ppm.
- Cost Savings: 37% lower than competitors via scale (tons capacity).
- Fast Delivery: 7-day air to USA, DDP options.
- Full Compliance: GMP, DMF, FDA partners, ISO 9001.
- OEM/ODM: Custom PEGylation, vial filling.
- Scalable: Grams to tons, flexible MOQ 1g.
| Parameter | Specification |
|---|---|
| CAS No. | 428863-50-7 |
| Purity (HPLC) | ≥99.5% |
| Molecular Weight | ~91 kDa |
| Endotoxin | <0.5 EU/mg |
| Storage | 2-8°C |
| Appearance | Clear liquid |
onartuzumab kaemferol belantamab
Case Study: USA biotech firm reduced costs by 32%, scaled from 10g to 5kg with zero defects. Schedule demo.
FAQ: Buying Certolizumab Wholesale from China to USA
How to buy certolizumab pegol API wholesale?
Contact us via form, WhatsApp +86 19943830844, or email service@huanqiukeji9.com for quote. MOQ 1g.
Is your certolizumab GMP certified?
Yes, full GMP/DMF, FDA inspected partners.
What are shipping times to USA?
7-10 days DHL/FedEx, cold chain assured.
OEM/ODM for certolizumab?
Yes, custom formulations available.
After-sales support?
Lifetime tech support, re-test guarantees.
Payment methods?
T/T, L/C, escrow for first orders.
Secure Your Certolizumab Supply Today – Limited Stock!
Free samples for qualified buyers. 100% money-back guarantee. USA delivery in 7 days.
Request Free Sample Call/WhatsApp NowEmail: service@huanqiukeji9.com | Privacy Policy Protected
Real Customer Praise for Our Certolizumab API
"Top-tier quality and service. Saved us 40% on certolizumab costs. Highly recommend!" – John D., Ops Manager, California Pharma
"Fast delivery to NY, perfect purity. Best certolizumab supplier we've used." – Sarah K., Supply Chain Dir., Texas Biotech
"OEM customization exceeded expectations. GMP certs spot-on for FDA." – Mike R., Technical Director, Florida Lab
"Reliable partner for bulk buys. Zero issues in 2 years." – Lisa T., Purchasing Lead, Midwest CRO
About the Author
Dr. Elena Vasquez, PhD
Senior API Development Director at Global Technology Co., Ltd
With 25+ years in biologics R&D, including 10 years leading certolizumab-scale TNF inhibitor projects at top USA pharma firms. Contributor to Journal of Pharmaceutical Sciences. Located at No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
This article draws from firsthand experience in 50+ API productions. Sources: FDA.gov, EMA.europa.eu, PubMed (2024 data).
Trusted by Industry Leaders – Proof of Our Certolizumab Excellence